Search clinical trials for: Aricept (donepezil IR 10 mg)

Total 1512 results

Eisai Inc.
Eisai Limited

Completed

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

Alzheimer's Disease

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Donepezil Hydrochloride 10 mg Tablets Under Fasting Condition

Healthy

India
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study for Donepezil Hydrochloride Tablets 10 mg Under Fed Condition

Healthy

India
Eisai Co., Ltd.

Completed

A Double-blind Study of E2020 (Donepezil Hydrochloride) in Patients With Dementia With Lewy Bodies (DLB) (Study E2020-J081-431)

Dementia With Lewy Bodies (DLB)

Japan
University Hospital, Lille
Innovative Medicines Initiative

Completed

Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical Development (PharmacogWP3)

Alzheimer Disease | Battery

France
Korea University Anam Hospital
Chong Kun Dang Pharmaceutical Corp.

Completed

Pharmacokinetic Comparisons of Two Donepezil Formulations

Alzheimer Disease

Korea, Republic of
Bayer
Merck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR Centre

Completed

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF (VITALITY-HFpEF)

Chronic Heart Failure With Preserved Ejection Fraction

Spain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
Merck Sharp & Dohme LLC

Completed

A Study to Test the Performance of the CogState Computerized Neuropsychological Battery in Patients With Alzheimer's Disease (0000-086)(COMPLETED)

Alzheimer's Disease
Merck Sharp & Dohme LLC

Completed

Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

Dementia
Eisai Inc.
Pfizer

Withdrawn

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

Severe Alzheimer's Disease

United States
Corium, Inc.

Completed

A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

Alzheimer Disease

United States
Pfizer

Completed

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

Alzheimer's Disease

United States
Eisai Co., Ltd.

Completed

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Dementia With Lewy Bodies (DLB)

Japan
Eisai Inc.
Eisai Co., Ltd.

Completed

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

Vascular Dementia

Philippines
Merck Sharp & Dohme LLC

Terminated

A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023)

Dementia | Alzheimer's Disease
Pfizer

Completed

Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid

Dementia | Alzheimer's Disease

United States
Samsung Medical Center
Eisai Korea Inc.

Completed

Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

Dementia | Alzheimer's Disease

Korea, Republic of
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil (Remember)

Cognitive Dysfunction | Memory Impairment

United States
Merck Sharp & Dohme LLC

Unknown

Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)

Mild Cognitive Impairment | Alzheimer's Disease
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.
Pfizer

Terminated

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17

Cognitive Dysfunction | Down Syndrome

United States
Eisai Inc.

Completed

An Evaluation Of The Efficacy And Safety Of Donepezil Hydrochloride (E2020) In Migraine Prophylaxis

Migraine Headache

United States
Eisai Inc.
Pfizer

Terminated

Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

Down Syndrome

United States
Stanford University

Completed

An Open-Label Trial of Donepezil in Fragile X Syndrome

Fragile X Syndrome

United States
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Eisai Inc.

Completed

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Mild Cognitive Impairment

United States
Samsung Medical Center
Eisai Korea Inc.

Completed

Clinical Trial of Donepezil Between the Naive Group and the Switching Group

Dementia | Alzheimer's Disease

Korea, Republic of
Lawson Health Research Institute

Completed

Donepezil and the Risk of Falls in Seniors With Cognitive Impairment

Mild Cognitive Impairment (MCI) | Gait | Falls | Balance

Canada
Bright Cloud International Corp
National Institute on Aging (NIA); Rutgers, The State University of New Jersey

Recruiting

Telerehabilitation Alzheimer's Disease Feasibility (TADF) (TADF)

Alzheimer Disease | Healthy Aging

United States
Pfizer

Completed

PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations

Healthy

United States
Pfizer

Completed

A Healthy Volunteer Trial to Gain Information About the Blood Concentrations of PF-06412562 After Oral Administration of a Modified Release Formulation in Fasted and Fed Conditions

Healthy

Belgium
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

Dementia With Lewy Body Disease

Japan
Birte Glenthoj
Pfizer; Rigshospitalet, Denmark; Glostrup University Hospital, Copenhagen

Terminated

The CAMPUS Project: Cholinergic Augmentation of Cognitive Deficits in Schizophrenia

Schizophrenia

Denmark
Eisai Co., Ltd.

Completed

A Study of Donepezil Hydrochloride in Patients With Dementia Associated With Cerebrovascular Disease

Dementia Associated With Cerebrovascular Disease

Korea, Republic of
Eisai Inc.
Eisai Limited

Completed

Efficacy and Safety of Donepezil Hydrochloride in Preadolescent and Adolescent Children With Attention Impairment Following Cancer Treatment

Attention Impairment

United States, Netherlands, France, Spain, United Kingdom, Germany, Argentina, Canada, Australia, Chile
Shanghai Synergy Pharmaceutical Sciences Co., Ltd.

Completed

Safety and Pharmacokinetic of Donepezil Pamoate in Healthy Subjects

AD

China
Vanderbilt University

Completed

Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease

Alzheimer's Disease

United States
Pfizer

Terminated

Observational Study Of Donepezil In Routine Clinical Practice

Alzheimer's Disease
Eisai Inc.
Pfizer

Completed

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Mild to Severe Alzheimer's Disease

United States
Asan Medical Center
Seoul St. Mary's Hospital; Seoul National University Bundang Hospital; Eisai... and other collaborators

Completed

Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg (ODESA)

Alzheimer's Disease

Korea, Republic of
Teva Pharmaceuticals USA

Completed

10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.

Healthy

United States
US Department of Veterans Affairs

Completed

Use of Donepezil for Treatment of Cocaine Dependence

Cocaine Abuse and Dependence

United States
Stanford University
National Institute of Mental Health (NIMH); Autism Speaks

Completed

Randomized Controlled Study of Donepezil in Fragile X Syndrome

Fragile X Syndrome

United States
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Alzheimer's Disease

Russian Federation, South Africa, Ukraine, United Kingdom
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Corium, Inc.

Completed

Crossover Pharmacokinetic (PK) Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers

Healthy Subjects

United States
Duke-NUS Graduate Medical School
GlaxoSmithKline

Completed

fMRI-behavioral Study of Cholinergic Augmentation With Donepezil in Healthy Sleep Deprived Adults

Sleep Deprivation

Singapore
Pfizer

Completed

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

Alzheimer Disease

Sweden
Beth Israel Deaconess Medical Center
National Institute on Aging (NIA)

Completed

Supporting the Health of Adults Undergoing Orthopedic Surgery During the Recovery Period (SHARP)

Delirium

United States

3

Subscribe